Although you can enjoy much of this website without javascript, we highly recommend that you enable it
in order to experience all available features.

Cookies on What Doctors Don't Tell You

We set cookies so you can manage your account and navigate the site, and to remember your cookie preferences so that you don't keep getting this message. To accept cookies, just keep browsing,
otherwise use the links on the right to adjust your cookie settings or find out more.

New guidelines now define half of all adults as having dangerously high blood pressure, requiring drugs for the rest of their lives. Lynne McTaggart and Bryan Hubbard offer alternatives to your doctor's prescription

Antipsychotics:

About the author:&nbsp

Doctors in nursing homes prescribe antipsychotic drugs with the same lack of thought that the service staff employs to place the order for tomorrow's newspapers

Doctors in nursing homes prescribe antipsychotic drugs with the same lack of thought that the service staff employs to place the order for tomorrow's newspapers. Most of the elderly residents have dementia, or so the doctors conclude, and so an antipsychotic, such as quetiapine, keeps them quiet and quells their agitation. This careless and lazy prescribing is little short of a criminal act. Doctors should (and do) know that antipsychotics are at best only mildly effective, but come with an enormous range of possible adverse reactions, including an increased risk of stroke. In short, the risks outweigh the benefits. This point has been forcibly driven home by a new study that discovered that quetiapine in particular 'significantly' contributes to cognitive decline. So here's the vicious circle: doctor suspects the patient of dementia, so the doctor prescribes quetiapine. Patient displays more convincing symptoms of dementia. Ergo, original diagnosis was right, and the treatment protocol vindicated. The study concludes that "quetiapine and rivastigine (another antipsychotic) seemed of no benefit in patients with dementia and agitation in institutional care, and quetiapine was associated with greater cognitive decline than placebo. Our results suggest that quetiapine should not be used in people with dementia". This is a damning conclusion (certainly by the standards of medical trials), but it's one we fear will be disregarded.